1 Study Coverage
1.1 Dengue Vaccine Product Introduction
1.2 Market Segments
1.3 Key Dengue Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dengue Vaccine Market Size Growth Rate by Type
1.4.2 CYD-TDV
1.4.3 DENVax or TAK-003
1.4.4 TetraVax-DV
1.4.5 TDENV PIV
1.4.6 V180
1.4.7 DNA vaccines
1.5 Market by Application
1.5.1 Global Dengue Vaccine Market Size Growth Rate by Application
1.5.2 Government institutions
1.5.3 Hospitals
1.5.4 NGOs
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dengue Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Dengue Vaccine Revenue 2015-2026
2.1.2 Global Dengue Vaccine Sales 2015-2026
2.2 Global Dengue Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dengue Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dengue Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dengue Vaccine Competitor Landscape by Players
3.1 Dengue Vaccine Sales by Manufacturers
3.1.1 Dengue Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Dengue Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Dengue Vaccine Revenue by Manufacturers
3.2.1 Dengue Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dengue Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dengue Vaccine Revenue in 2019
3.2.5 Global Dengue Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dengue Vaccine Price by Manufacturers
3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dengue Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dengue Vaccine Market Size by Type (2015-2020)
4.1.1 Global Dengue Vaccine Sales by Type (2015-2020)
4.1.2 Global Dengue Vaccine Revenue by Type (2015-2020)
4.1.3 Dengue Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dengue Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Dengue Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Dengue Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Dengue Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dengue Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dengue Vaccine Market Size by Application (2015-2020)
5.1.1 Global Dengue Vaccine Sales by Application (2015-2020)
5.1.2 Global Dengue Vaccine Revenue by Application (2015-2020)
5.1.3 Dengue Vaccine Price by Application (2015-2020)
5.2 Dengue Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Dengue Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Dengue Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Dengue Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dengue Vaccine by Country
6.1.1 North America Dengue Vaccine Sales by Country
6.1.2 North America Dengue Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dengue Vaccine Market Facts & Figures by Type
6.3 North America Dengue Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Dengue Vaccine by Country
7.1.1 Europe Dengue Vaccine Sales by Country
7.1.2 Europe Dengue Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dengue Vaccine Market Facts & Figures by Type
7.3 Europe Dengue Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dengue Vaccine by Region
8.1.1 Asia Pacific Dengue Vaccine Sales by Region
8.1.2 Asia Pacific Dengue Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dengue Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Dengue Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dengue Vaccine by Country
9.1.1 Latin America Dengue Vaccine Sales by Country
9.1.2 Latin America Dengue Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dengue Vaccine Market Facts & Figures by Type
9.3 Central & South America Dengue Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dengue Vaccine by Country
10.1.1 Middle East and Africa Dengue Vaccine Sales by Country
10.1.2 Middle East and Africa Dengue Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dengue Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Dengue Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck Sharp & Dohme
11.2.1 Merck Sharp & Dohme Corporation Information
11.2.2 Merck Sharp & Dohme Description and Business Overview
11.2.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Sharp & Dohme Dengue Vaccine Products Offered
11.2.5 Merck Sharp & Dohme Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Dengue Vaccine Products Offered
11.3.5 Sanofi Related Developments
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Corporation Information
11.4.2 Takeda Pharmaceuticals Description and Business Overview
11.4.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Takeda Pharmaceuticals Dengue Vaccine Products Offered
11.4.5 Takeda Pharmaceuticals Related Developments
11.5 GeneOne Life Sciences
11.5.1 GeneOne Life Sciences Corporation Information
11.5.2 GeneOne Life Sciences Description and Business Overview
11.5.3 GeneOne Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GeneOne Life Sciences Dengue Vaccine Products Offered
11.5.5 GeneOne Life Sciences Related Developments
11.6 Medigen Biologics
11.6.1 Medigen Biologics Corporation Information
11.6.2 Medigen Biologics Description and Business Overview
11.6.3 Medigen Biologics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Medigen Biologics Dengue Vaccine Products Offered
11.6.5 Medigen Biologics Related Developments
11.7 Panacea Biotec
11.7.1 Panacea Biotec Corporation Information
11.7.2 Panacea Biotec Description and Business Overview
11.7.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Panacea Biotec Dengue Vaccine Products Offered
11.7.5 Panacea Biotec Related Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Corporation Information
11.8.2 Sun Pharmaceutical Description and Business Overview
11.8.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sun Pharmaceutical Dengue Vaccine Products Offered
11.8.5 Sun Pharmaceutical Related Developments
11.9 U.S NIH
11.9.1 U.S NIH Corporation Information
11.9.2 U.S NIH Description and Business Overview
11.9.3 U.S NIH Sales, Revenue and Gross Margin (2015-2020)
11.9.4 U.S NIH Dengue Vaccine Products Offered
11.9.5 U.S NIH Related Developments
11.10 Vabiotec
11.10.1 Vabiotec Corporation Information
11.10.2 Vabiotec Description and Business Overview
11.10.3 Vabiotec Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Vabiotec Dengue Vaccine Products Offered
11.10.5 Vabiotec Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dengue Vaccine Market Estimates and Projections by Region
12.1.1 Global Dengue Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Dengue Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Dengue Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Dengue Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Dengue Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Dengue Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Dengue Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Dengue Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dengue Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dengue Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dengue Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dengue Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Dengue Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Dengue Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Dengue Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dengue Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dengue Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dengue Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dengue Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dengue Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dengue Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
GlaxoSmithKline、Merck Sharp & Dohme、Sanofi、Takeda Pharmaceuticals、GeneOne Life Sciences、Medigen Biologics、Panacea Biotec、Sun Pharmaceutical、U.S NIH、Vabiotec
【免責事項】
https://www.globalresearch.jp/disclaimer